Search

Your search keyword '"Bavarian Nordic A/S -- Intellectual property"' showing total 81 results
Start Over Descriptor "Bavarian Nordic A/S -- Intellectual property"
81 results on '"Bavarian Nordic A/S -- Intellectual property"'

1. Researchers Submit Patent Application, 'Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA', for Approval (USPTO 20250002606)

Subjects
Bavarian Nordic A/S -- Intellectual property, Oncology, Experimental, Antineoplastic agents -- Intellectual property, Viral antibodies, Immunotherapy, Amino acids -- Intellectual property, Cancer -- Care and treatment -- Research, Vaccines -- Intellectual property, Antibodies, Monoclonal antibodies, Antimitotic agents -- Intellectual property, Health
Abstract

2025 JAN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Habjan, Matthias [...]

Published
2025

2. Patent Application Titled 'Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA)' Published Online (USPTO 20240392257)

Subjects
Bavarian Nordic A/S -- Intellectual property, Gene expression, RNA, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2024

3. Patent Application Titled 'Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or Agonist' Published Online (USPTO 20240269254)

Subjects
Bavarian Nordic A/S -- Intellectual property, Immunotherapy, Cancer -- Care and treatment, Vaccines -- Intellectual property, Monoclonal antibodies, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 SEP 4 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2024

4. Patent Issued for Methods and compositions for inducing protective immunity against filovirus infection (USPTO 11918639)

Subjects
Bavarian Nordic A/S -- Intellectual property, Marburg virus disease -- Methods, Vaccines -- Intellectual property -- Methods, Pharmaceutical industry -- Intellectual property, Health
Abstract

2024 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Bavarian Nordic A/S (Kvistgaard, Denmark) has been issued patent number 11918639, according to news reporting [...]

Published
2024

5. Patent Application Titled 'Compositions and Methods for Enhancing the Stability of Transgenes in Poxviruses' Published Online (USPTO 20210338788)

Subjects
Bavarian Nordic A/S -- Intellectual property, Immunotherapy -- Methods, Amino acids -- Methods -- Intellectual property, Vaccines -- Intellectual property -- Methods, Physical fitness -- Methods, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 NOV 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2021

6. Patent Issued for Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA (USPTO 11723964)

Subjects
Bavarian Nordic A/S -- Intellectual property, Antineoplastic agents -- Intellectual property, Viral antibodies, Immunotherapy, Amino acids -- Intellectual property, Cancer -- Care and treatment, Vaccines -- Intellectual property, Antibodies, Monoclonal antibodies, Pharmaceutical industry -- Intellectual property, Antimitotic agents -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2023 SEP 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Bavarian Nordic A/S (Hellerup, Denmark) has been issued patent number 11723964, according to news reporting [...]

Published
2023

7. Patent Application Titled 'Storage Improved Poxvirus Compositions' Published Online (USPTO 20210187100)

Subjects
Bavarian Nordic A/S -- Intellectual property, Neomycin -- Intellectual property, Povidone -- Intellectual property, Physical fitness, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2021

8. 'Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer' in Patent Application Approval Process (USPTO 20230190922)

Subjects
Bavarian Nordic A/S -- Intellectual property, B cells, Cancer -- Care and treatment, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health
Abstract

2023 JUL 12 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventors Habjan, Matthias (Puchheim, DE); Hausmann, Jurgen (Gundelfingen, DE); Hinterberger, [...]

Published
2023

9. 'Conditions Improving Poxvirus Stability' in Patent Application Approval Process (USPTO 20230114464)

Subjects
Bavarian Nordic A/S -- Intellectual property, Neomycin -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Biological sciences, Business
Abstract

2023 MAY 1 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent application by the inventors Kalla, Markus (Penzberg, DE); Kjaer, Katrine (Bronshoj, DK), [...]

Published
2023

10. Patent Issued for Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine (USPTO 11571471)

Subjects
Bavarian Nordic A/S -- Intellectual property, Encephalitis, Equine encephalomyelitis, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2023 MAR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Bavarian Nordic A/S (Hellerup, Denmark) has been issued patent number 11571471, according to news reporting [...]

Published
2023

11. 'Combination Therapy for Treating Cancer With an Antibody and Intravenous Administration of a Recombinant MVA' in Patent Application Approval Process (USPTO 20220249636)

Subjects
Bavarian Nordic A/S -- Intellectual property, Antineoplastic agents -- Intellectual property, Viral antibodies, Immunotherapy, Cancer -- Care and treatment, Antibodies, Monoclonal antibodies, Pharmaceutical industry -- Intellectual property, Antimitotic agents -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2022 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors HABJAN, Matthias (Puchheim, DE); HOCHREIN, Hubertus (Munich, DE); LAUTERBACH, [...]

Published
2022

12. Patent Issued for Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens (USPTO 11338030)

Subjects
Bavarian Nordic A/S -- Intellectual property, Marburg virus disease, RNA, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2022

13. Patent Issued for Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody (USPTO 11273211)

Subjects
Bavarian Nordic A/S -- Intellectual property, Antineoplastic agents -- Intellectual property, Viral antibodies, Immunotherapy, Amino acids -- Intellectual property, Cancer -- Care and treatment, Vaccines -- Intellectual property, Antibodies, Monoclonal antibodies, Pharmaceutical industry -- Intellectual property, Antimitotic agents -- Intellectual property, Health
Abstract

2022 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Bavarian Nordic A/S (Hellerup, Denmark) has been issued patent number 11273211, according to news reporting [...]

Published
2022

14. Patent Application Titled 'Therapy for Treating Cancer with an Intratumoral or Intravenous Administration of a Recombinant MVA Encoding 4-1BBL (CD137L) and/or CD40L' Published Online (USPTO 20220000997)

Subjects
Bavarian Nordic A/S -- Intellectual property, Immunotherapy, B cells, Cancer -- Care and treatment, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 JAN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2022

15. Patent Issued for Methods and compositions for inducing protective immunity against filovirus infection (USPTO 11173201)

Subjects
Bavarian Nordic A/S -- Intellectual property, Marburg virus disease -- Methods, Vaccines -- Intellectual property -- Methods, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 DEC 8 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Bavarian Nordic A/S (Kvistgaard, Denmark) has been issued patent number 11173201, according to news reporting [...]

Published
2021

16. 'Recombinant Modified Vaccinia Virus Ankara (MVA) Equine Encephalitis Virus Vaccine' in Patent Application Approval Process (USPTO 20210205439)

Subjects
Bavarian Nordic A/S -- Intellectual property, Encephalitis, Equine encephalomyelitis, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health
Abstract

2021 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventors Kalla, Markus (Penzberg, DE); Steigerwald, Robin (Munich, DE), filed [...]

Published
2021

18. Patent Issued for Use Of Oil And Water Emulsions For Increasing B Cell Responses With Modified Vaccinia Ankara Virus (USPTO 10,653,766)

Subjects
Bavarian Nordic A/S -- Intellectual property, Tumor antigens, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Antigens, Immune response, Vaccinia, Tumors, Editors, Health
Abstract

2020 JUN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Bavarian Nordic A/S (Kvistgaard, Denmark) has been issued patent number 10,653,766, according to news reporting [...]

Published
2020

19. Patent Application Titled 'Methods And Compositions For Inducing Protective Immunity Against A Marburg Virus Infection' Published Online (USPTO 20190224301)

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines -- Methods, Marburg virus disease -- Methods, Ebola virus -- Methods, Amino acids -- Methods, Virus diseases -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Editors, Health
Abstract

2019 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2019

20. 'Recombinant Modified Vaccinia Virus Ankara (Mva) Foot and Mouth Disease Virus (Fmdv) Vaccine' in Patent Application Approval Process (USPTO 20180185466)

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines, Foot and mouth disease, Livestock, Communicable diseases, Patents, Pharmaceutical industry -- Intellectual property -- International economic relations, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2018 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- A patent application by the inventors Steigerwald, Robin (Munich, DE); Kalla, Markus (Penzberg, DE), [...]

Published
2018

21. 'Recombinant Modified Vaccinia Virus Ankara (Mva) Foot and Mouth Disease Virus (Fmdv) Vaccine' in Patent Application Approval Process (USPTO 20180185466)

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines, Foot and mouth disease, Livestock, Communicable diseases, Patents, Pharmaceutical industry -- Intellectual property -- International economic relations, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2018 JUL 23 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- A patent application by the inventors Steigerwald, Robin (Munich, DE); Kalla, Markus (Penzberg, DE), [...]

Published
2018

22. Researchers Submit Patent Application, 'Pr13.5 Promoter for Robust T-Cell and Antibody Responses', for Approval (USPTO 20180111966)

Subjects
Bavarian Nordic A/S -- Intellectual property, Patents, Vaccination, Antibodies, Pharmaceutical industry -- Intellectual property, T cells, Patent/copyright issue, Health
Abstract

2018 MAY 14 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Steigerwald, Robin [...]

Published
2018

23. U.S. patent granted for modified virus ankara

Subjects
Bavarian Nordic A/S -- Intellectual property, Health, Patents, Virus diseases, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health
Abstract

Bavarian Nordic A/S (BAVA) announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company that further strengthens its intellectual property position on modified virus [...]

Published
2005

24. Patent Issued for Use of a Modified Poxvirus for the Rapid Induction of Immunity against a Poxvirus Or Other Infectious Agents (USPTO 9265823)

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health, Social sciences
Abstract

2016 MAR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Bioterrorism Week -- A patent by the inventors Chaplin, Paul (Grafelfing, DE); Mateo, Luis (Chapel Hill, AU), filed [...]

Published
2016

25. Patent Issued for Single High Dose of MVA Induces a Protective Immune Response in Neonates and Infants (USPTO 9707291)

Subjects
Bavarian Nordic A/S -- Intellectual property, Cancer vaccines, Newborn infants, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

2017 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2017

26. Patent Issued for Agonists and Antagonists of Toll-Like Receptor (TLR) 13 (USPTO 9556439)

Subjects
Bavarian Nordic A/S -- Intellectual property, Cancer genetics, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

2017 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent by the inventors Kirschning, Carsten (Essen, DE); Bauer, Stefan (Marbury-Michelbach, DE); [...]

Published
2017

27. Patent Issued for Immediate Protection against Pathogens via MVA

Subjects
Bavarian Nordic A/S -- Intellectual property, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health, Social sciences
Abstract

By a News Reporter-Staff News Editor at Bioterrorism Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Hochrein, Hubertus (Munich, DE); O'Keeffe, Meredith (Munich, DE), [...]

Published
2015

28. 'Use of a Modified Poxvirus for the Rapid Induction of Immunity against a Poxvirus Or Other Infectious Agents' in Patent Application Approval Process

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health, Social sciences, Dryvax (Medication)
Abstract

By a News Reporter-Staff News Editor at Bioterrorism Week -- A patent application by the inventors CHAPLIN, Paul (Grafelfing, DE); MATEO, Luis (Chapel Hill, AU), filed on July 10, 2014, [...]

Published
2014

29. Patent Issued for Use of a Modified Poxvirus for the Rapid Induction of Immunity against a Poxvirus Or Other Infectious Agents

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health, Social sciences
Abstract

By a News Reporter-Staff News Editor at Bioterrorism Week -- Bavarian Nordic A/S (Kvistgaard, DK) has been issued patent number 8808709, according to news reporting originating out of Alexandria, Virginia, [...]

Published
2014

30. Patent Issued for Replication Deficient Recombinant Viruses Expressing Antigens Regulated by Transcriptional Control Elements Comprising Multiple Elements (USPTO 9163237)

Subjects
Bavarian Nordic A/S -- Intellectual property, Antigens, AIDS vaccines, Transcription (Genetics), Patents, Virus diseases -- Genetic aspects, Infection -- Genetic aspects, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health
Abstract

2015 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2015

31. Patent Issued for Immediate Protection against Pathogens via MVA

Subjects
Bavarian Nordic A/S -- Intellectual property, Biotechnology industry -- Intellectual property, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health, Social sciences
Abstract

By a News Reporter-Staff News Editor at Bioterrorism Week -- Bavarian Nordic A/S (Kvistgaard, DK) has been issued patent number 8268328, according to news reporting originating out of Alexandria, Virginia, [...]

Published
2012

32. Bavarian Nordic MVA-BN technology patent upheld in Europe

Subjects
Bavarian Nordic A/S -- Intellectual property, Biotechnology industry -- Intellectual property, Patents, Patent infringement, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, General interest, News, opinion and commentary
Abstract

Oct 06, 2010 (NORDIC BUSINESS REPORT via COMTEX) -- 6 October 2010 - Danish biotech company Bavarian Nordic A/S (CPH: BAVA) said late on Tuesday its core patent for the [...]

Published
2010

33. Bavarian Nordic successfully defends MVABN patent in Europe

Subjects
Bavarian Nordic A/S -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry -- Intellectual property, Patents, Patent/copyright issue, Business, Business, international
Abstract

(From Pharma) M2PHARMA-October 6, 2010-Bavarian Nordic successfully defends MVA-BN patent in Europe (C)2010 M2 COMMUNICATIONS http://www.m2.com 6 October 2010 - Danish biotechnology company Bavarian Nordic AS (CPH: BAVA) said yesterdat [...]

Published
2010

34. Bavarian Nordic gets core patent upheld in Europe

Subjects
Bavarian Nordic A/S -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biotechnology industry -- Intellectual property, Patent infringement, Patents, Patent/copyright issue, Business, Business, international
Abstract

(From Pharma) M2PHARMA-October 6, 2010-Bavarian Nordic gets core patent upheld in Europe (C)2010 M2 COMMUNICATIONS http://www.m2.com 6 October 2010 - Danish biotech company Bavarian Nordic A/S (CPH: BAVA) said late [...]

Published
2010

35. Patent Application Titled 'Promoters for Recombinant Viral Expression' Published Online

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccines, Gene therapy, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors STEIGERWALD, [...]

Published
2014

36. Patent Issued for Modulation of Immune Responses by the Poxviral K4 Protein

Subjects
Bavarian Nordic A/S -- Intellectual property, Immune response, Vaccines, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Hausmann, Jurgen (Gundelfingen, DE); [...]

Published
2014

37. Patent Issued for Promoters for Recombinant Viral Expression

Subjects
Bavarian Nordic A/S -- Intellectual property, Gene therapy, Patents, Pharmaceutical industry -- Intellectual property, Virus diseases, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Steigerwald, Robin [...]

Published
2014

38. 'Replication Deficient Recombinant Viruses Expressing Antigens Regulated by Transcriptional Control Elements Comprising Multiple Elements' in Patent Application Approval Process

Subjects
Bavarian Nordic A/S -- Intellectual property, Antigens, Infection -- Genetic aspects, Vaccines, Patents, Genetic transcription, Pharmaceutical industry -- Intellectual property, Virus diseases -- Genetic aspects, Patent/copyright issue, Government, Political science
Abstract

By a News Reporter-Staff News Editor at Politics & Government Week -- A patent application by the inventors HAUSMANN, Jurgen (Gundelfingen, DE); Baur, Karen (Munich, DE); Brinkmann, Kay (Munich, DE), [...]

Published
2014

39. 'Replication Deficient Recombinant Viruses Expressing Antigens Regulated by Transcriptional Control Elements Comprising Multiple Elements' in Patent Application Approval Process

Subjects
Bavarian Nordic A/S -- Intellectual property, Antigens, Vaccines, Patents, Genetic transcription, Pharmaceutical industry -- Intellectual property, Virus diseases -- Genetic aspects, Patent/copyright issue, Biological sciences, Health
Abstract

By a News Reporter-Staff News Editor at Life Science Weekly -- A patent application by the inventors HAUSMANN, Jurgen (Gundelfingen, DE); Baur, Karen (Munich, DE); Brinkmann, Kay (Munich, DE), filed [...]

Published
2014

40. Acambis wins MVA patents case against Bavarian Nordic at ITC UPDATE

Subjects
Acambis PLC -- Intellectual property, Bavarian Nordic A/S -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Business, international
Abstract

(From AFX UK (Focus)) (adds statement from BN, to appeal) LONDON (AFX) - Acambis PLC said an administrative law judge at the International Trade Commission ('ITC') has ruled in favour [...]

Published
2006

41. Acambis wins MVA patents case against Bavarian Nordic at ITC

Subjects
Acambis PLC -- Intellectual property, Bavarian Nordic A/S -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Business, international
Abstract

(From AFX UK (Focus)) LONDON (AFX) - Acambis PLC said an administrative law judge at the International Trade Commission ('ITC') has ruled in favour of Acambis in the dispute between [...]

Published
2006

42. Bavarian Nordic, Producer of New Smallpox Vaccine, Gains European Patent, Awaits U.S. Response to Supply

Subjects
Bavarian Nordic A/S -- Intellectual property, Biological products industry -- Intellectual property, Immunotherapy, Smallpox, Smallpox vaccine -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Science and technology, European Patent Organisation. European Patent Office -- Intellectual property
Abstract

WASHINGTON, Jan 5, 2006 (U.S. Newswire via COMTEX) -- Bavarian Nordic, the Denmark-based biopharmaceutical company that has developed a new smallpox vaccine and submitted a proposal to supply it to [...]

Published
2006

43. Patent Issued for Replication Deficient Recombinant Viruses Expressing Antigens Regulated by Transcriptional Control Elements Comprising Multiple Elements

Subjects
Bavarian Nordic A/S -- Intellectual property, Antigens, Infection -- Genetic aspects, Patents, Genetic transcription, AIDS vaccines, Pharmaceutical industry -- Intellectual property, Virus diseases -- Genetic aspects, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at AIDS Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Hausmann, Jurgen (Gundelfingen, DE); Baur, Karen (Munich, DE); [...]

Published
2014

44. Patent Issued for Purification of Vaccinia Viruses Using Hydrophobic Interaction Chromatography

Subjects
Bavarian Nordic A/S -- Intellectual property, Chromatography, Vaccinia, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Post Hansen, Sara (Hoersholm, [...]

Published
2013

45. Patent Issued for Modified Vaccinia Ankara Virus Variant and Cultivation Method

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccinia -- Methods, Patents -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at AIDS Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Chaplin, Paul (Grafelfing, DE); Howley, Paul (Berwick, AU); [...]

Published
2013

46. Patent Issued for Induction of Dendritic Cell Development with Macrophage-Colony Stimulating Factor (M-CSF)

Subjects
Bavarian Nordic A/S -- Intellectual property, Macrophage colony stimulating factor, Gene therapy, Systemic lupus erythematosus, Acute lymphocytic leukemia, Dendritic cells, Patents, Macrophages, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Bavarian Nordic A/S (Kvistgaard, DK) has been issued patent number 8445275, according to news reporting originating out of [...]

Published
2013

47. Patent Issued for Purification of Vaccinia Virus- and Recombinant Vaccinia Virus-Based Vaccines

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccinia, Patents, Vaccines -- Intellectual property, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Djurup, Rene (Gentofte, DK); [...]

Published
2013

48. Patent Issued for Optimized Early-Late Promoter Combined with Repeated Vaccination Favors Cytotoxic T Cell Response against Recombinant Antigen in MVA Vaccines

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccination, T cells, Antigens, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biological sciences, Health
Abstract

By a News Reporter-Staff News Editor at Life Science Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Hausmann, Jurgen (Gundelfingen, [...]

Published
2013

49. Patent Issued for Induction of Dendritic Cell Development with Macrophage-Colony Stimulating Factor (M-CSF)

Subjects
Bavarian Nordic A/S -- Intellectual property, Macrophage colony stimulating factor, Gene therapy, Systemic lupus erythematosus, Dendritic cells, Macrophages, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Biotechnology industry, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Bavarian Nordic A/S (Kvistgaard, DK) has been issued patent number 8354275, according to news reporting originating out of [...]

Published
2013

50. Researchers Submit Patent Application, 'Modified Vaccinia Ankara Virus Variant', for Approval

Subjects
Bavarian Nordic A/S -- Intellectual property, Vaccinia, Clinical trials, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors CHAPLIN, PAUL (GRAFELFING, DE); HOWLEY, PAUL [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results